Pharma Company And Drug Testing Industry Claim Trump's Rescheduling Move Will 'Increase Marijuana Abuse'
Pharmaceutical and drug testing industries warn that President Trump's marijuana rescheduling move could lead to increased drug abuse.
3 independently sourced, verified news trends involving DEA.
This hub is built from stories supported by at least four independent sources and accepted by Newsylist's verification pass. Qualifying coverage spans 2 news categories, from Jun 28, 2026 through Jul 19, 2026.
Open any card for the source list, timeline and coverage-velocity evidence. Raw detections and extractive-only records are excluded from this page.
Pharmaceutical and drug testing industries warn that President Trump's marijuana rescheduling move could lead to increased drug abuse.
The Trump administration is navigating a complex regulatory split between supporting kratom allies and DEA efforts to ban potent derivatives.
Missing woman's ties to Olney house spark massive investigation